| Financial Year |
March 31 2023 |
| Monetary Funds |
698,200,011.17 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,877,863.35 |
| Accounts Receivable |
917,642,878.59 |
| Advances to Suppliers |
22,455,045.93 |
| Other Receivables |
53,105,485.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
339,973,880.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,636,307.92 |
| Total Current Assets |
2,056,891,472.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
175,881,107.31 |
| Under-construction Projects |
27,823,120.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,000,681.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
309,240.24 |
| Deferred Income Tax Assets |
13,067,174.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
281,338,995.37 |
| Total Assets |
2,338,230,467.96 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000.00 |
| Accounts Payable |
645,147,264.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,740,541.73 |
| Taxes Payable |
7,626,391.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,095,818.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,710,046.19 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
757,647,789.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,926,989.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
24,958,513.98 |
| Total Liabilities |
782,606,303.06 |
| Paid-In Capital(Or Share Stock) |
461,135,972.00 |
| Capital Surplus |
752,792,768.77 |
| Surplus Reserve |
48,575,093.43 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
300,727,829.97 |
| Minority Stockholder's Interest |
-7,607,499.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,563,231,664.17 |
| Owner's Equity（Stockholder's Equity） |
1,555,624,164.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,338,230,467.96 |
